Prescription required. A licensed provider will review your information and determine if this medication is appropriate for you. Price reflects retail cost and may vary with insurance coverage.
Image for illustrative purposes only
What it is
About Zepbound®
Zepbound® (tirzepatide injection) is an FDA-approved prescription medication indicated for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related condition, when used in conjunction with a reduced-calorie diet and increased physical activity. Zepbound® is manufactured by Eli Lilly and Company. It is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptor agonist — activating both hormone receptors to reduce appetite and improve metabolic regulation. Zepbound® is not a compounded medication — it is an FDA-approved finished drug product.
How to take it
Administration & dosing
Zepbound® is administered as a once-weekly subcutaneous injection using a pre-filled autoinjector pen. Your licensed provider will determine the appropriate starting dose and escalation schedule based on your individual medical history. The injection is typically given in the stomach, thigh, or upper arm. Doses are escalated gradually over several weeks under provider supervision. Store pen injectors in the refrigerator between 36°F and 46°F. Do not freeze. Do not use if you or a family member have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
What you get
Included with every plan
Physician consultation
Unlimited provider messaging
Insurance prior auth support
Free shipping on every refill
Progress tracking portal
Ongoing dose guidance
Side effects
Potential side effects
Zepbound® has an FDA-approved prescribing label with a full list of warnings and contraindications. Common side effects include nausea, diarrhea, vomiting, constipation, stomach pain, injection-site reactions, fatigue, and decreased appetite. Serious risks include: thyroid C-cell tumors (contraindicated in patients with a personal or family history of MTC or MEN 2), pancreatitis, gallbladder disease, increased heart rate, suicidal behavior and ideation, and hypoglycemia. Tell your provider about all medical conditions and medications before starting. This is not a complete list — refer to the full FDA-approved prescribing information.
FAQ
Frequently asked questions
$1,828/month at retail pricing. Actual cost may be significantly lower with insurance coverage. Our team provides insurance prior authorization support to help maximize your benefits.
Zepbound® is an FDA-approved finished drug product manufactured by Eli Lilly. Compounded tirzepatide is prepared by licensed compounding pharmacies and is not FDA-approved. Your licensed provider can discuss which option may be appropriate for your individual situation.
Zepbound® and Mounjaro® both contain tirzepatide but are approved for different indications. Zepbound® is FDA-approved for chronic weight management. Mounjaro® is FDA-approved for type 2 diabetes management. Your provider will determine which is appropriate based on your medical history.
Coverage varies by insurance plan. Our team includes insurance prior authorization support to help navigate the approval process. Coverage is not guaranteed.
No. Insurance is never required to get started. However, insurance prior authorization support is included if you choose to use your insurance. Our team will help navigate the prior auth process on your behalf.
Vytora Health is available in 44 US states through our partner pharmacy Jungle Jim's Pharmacy. We are currently unable to serve patients in California, Nevada, New Jersey, North Carolina, Texas, Massachusetts, Mississippi, New Hampshire, West Virginia, and Delaware. Contact support@vytorahealth.com with questions.
Your prescription is fulfilled at a licensed pharmacy and shipped directly to your door in discreet packaging. Shipping is always free.
Yes. Wegovy® and Zepbound® are FDA-approved prescription medications. They are not compounded products. A prescription from a licensed healthcare provider is required.
Ready to get started?
Answer a few questions and get matched with a licensed provider today.
*Prescription required. A licensed healthcare provider will review your information and prescribe only if medically appropriate. Wegovy® and Zepbound® are FDA-approved prescription medications. FDA-approved medications carry their own FDA-approved labeling, warnings, and contraindications. This page is for informational purposes only and does not constitute medical advice. Individual results are not guaranteed.
Wegovy® is a registered trademark of Novo Nordisk A/S. Zepbound® is a registered trademark of Eli Lilly and Company. Neither company sponsors or endorses Vytora Health. Vytora Health provides access to licensed healthcare providers who may prescribe these medications if medically appropriate.
Pricing reflects current retail market rates and may vary. Insurance coverage is not guaranteed. Vytora Health does not manufacture or distribute medications. All prescriptions are issued by independent licensed clinicians.
